Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses

Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses

US Patent 8388971 · Granted Mar 5, 2013

Estimated economic value: $213,487,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bivalent bispecific antibody and preparation method thereof, coding gene, host c2025
Compositions and methods for treatment of thyroid eye disease2025
Anti-CD47 monoclonal antibody and use thereof2025
Humanized anti-A β monoclonal antibody and application thereof2025
Antibodies that bind to C1S and uses thereof2025
Method, apparatus, device and medium for processing group information2024
Antibodies that bind to cis and uses thereof2024
Antibody drug conjugates (ADC) that bind to 158P1D7 proteins2023
Compositions and methods for treatment of thyroid eye disease2023
Antibodies directed to the deletion mutants of epidermal growth factor receptor 2022
Antibodies directed to the deletion mutants of epidermal growth factor receptor 2022
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins2022